Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Eric J Toone

1PUBLICATIONS
13CO-AUTHORS
Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 09, 2023
Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens.

Jinshi Zhao, C Skyler Cochrane, Javaria Najeeb

Pageof 1

Frequent Collaborators

1 joint publications

Jinshi Zhao

1 joint publications

C Skyler Cochrane

1 joint publications

Javaria Najeeb

1 joint publications

David Gooden

1 joint publications

Nadine Lemaitre

1 joint publications

Kate Newns

1 joint publications

Robert A Nicholas

1 joint publications

Ziqiang Guan

1 joint publications

Joshua T Thaden

1 joint publications

Vance G Fowler

Frequent Collaborators

1 joint publications

Jinshi Zhao

1 joint publications

C Skyler Cochrane

1 joint publications

Javaria Najeeb

1 joint publications

David Gooden

Top Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on : Jul 26, 2017

12.4K
See more related videos

Top Related Videos

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on : Jul 26, 2017

12.4K
See more related videos